Managing toxic thyroid adenoma: A cost-effectiveness analysis

European Journal of Endocrinology

Volumn 146, Issue 3, 2002, Pages 283-294

  Vidal Trécan, Gwenaëlle M ^a   Stahl, James E ^a   Durand Zaleski, Isabelle ^a  

^a CHU Cochin Port Royal ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEVOTHYROXINE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

ADOLESCENT; ADULT; AGE; AGED; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEPATITIS; HUMAN; HYPOTHYROIDISM; INFANT DISEASE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SUBTOTAL THYROIDECTOMY; SURGICAL MORTALITY; THYROID ADENOMA; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME; VASCULITIS;

EID: 0036201894     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460283     Document Type: Article

References (80)

1. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey
2. Iodine intake and the pattern of thyroid disorders: A comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark
3. Incidence of different forms of thyroid dysfunction and its degrees in an iodine sufficient area
4. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency
5. The spectrum of thyroid disorders in an iodine-deficient community: The Pescopagano survey
6. The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990
7. Toxic adenoma and toxic multinodular goiter
8. Antithyroid drugs
9. The management of hyperthyroidism
10. Treatment of benign nodular thyroid disease
11. Treatment of toxic solitary thyroid nodules: Surgery versus radioactive iodine
12. The surgical treatment of toxic nodular goitres
13. The autonomous functioning thyroid nodule: Therapeutic considerations
14. The treatment of autonomous functioning thyroid nodules
15. Thyroid autonomous nodule. Surgical treatment and post-operative outcome. Retrospective study of 102 cases
16. Iodine-131 treatment of hyperthyroidism: Current issues
17. Controversies in the management of cold, hot, and occult thyroid nodules
18. The autonomously functioning thyroid adenoma: Clinical consideration (Editorial)
19. The thyroid gland
20. The autonomous nodule of the thyroid: Correlation of patient age, nodule size and functional status
21. Current management of the patient with autonomously functioning nodular goiter
22. Decision Maker 3.0. Improved decision analysis by personal computer
23. Clinical decision analysis by personal computer
24. Decision analysis
25. A convenient approximation of life expectancy (the 'DEALE'). II Use in medical decision making
26. The cold thyroid nodule: An analysis of diagnostic and therapeutic options
27. Differentiated thyroid cancer: Reexamination of risk groups and outcome of treatment
28. Survival of Danish cancer patients 1943-1987. Eye, brain and nervous system, thyroid, bone and connective tissue
29. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose
30. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease
31. One thousand health-related quality-of-life estimates
32. Outcome of surgery in 300 cases of hyperthyroidism, including 40 with cardiotoxicity
33. Solitary autonomously functioning thyroid lesions. Diagnosis, clinical features and pathogenetic considerations
34. Follow-up of solitary autonomous thyroid nodules treated with 131-I
35. 306 cases of toxic adenoma: Clinical aspects, findings in radioiodine diagnostics, radio-chromatography and histology; Results of 131-I and surgical treatment
36. Results of the treatment of toxic thyroid adenomas by 131-I
37. The incidence of hypothyroidism after radioactive iodine (131-I) therapy for autonomous hyperfunctioning thyroid nodule evaluated by means of life-table method
38. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine
39. On the hyperfunctioning solitary thyroid nodule
40. Cost-utility analysis
41. Economic analysis of diagnostic and therapeutic methods in cases of cold thyroid nodules
42. Chirurgie de l'hyperthyroïdie (Réflexions thérapeutiques et nosologiques. A propos d'une série personnelle de 2385 interventions)
43. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study
44. Long-term studies of solitary autonomous thyroid nodules
45. Thyroid carcinoma in thyrotoxic patients treated by surgery
46. Incidence of cancer in thyroid nodules
47. Hyperthyroidism and concurrent thyroid malignancies
48. Concurrent hyperthyroidism and thyroid carcinoma
49. Unrecognized etiological aspects of toxic thyroid adenoma (toxic adenoma on a thyroidectomy stump, toxic adenoma and cancer)
50. Complications and sequelae of thyroid surgery
51. Risk of anesthesia
52. L'expérience des rapporteurs. Etude statistique: Les données générales et les complications
53. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity
54. Use of 131 iodine for the treatment of hyperthyroidism in adults
55. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism
56. 131I treatment of diffuse and nodular toxic goitre with and without antithyroid agents
57. 131I-therapy of solitary autonomous thyroid nodules: Effect on thyroid size and early hypothyroidism
58. Radioiodine treatment of solitary functioning thyroid nodules
59. Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule
60. Cancer incidence following treatment of hyperthyroidism
61. Malignant thyroid tumors after iodine-131 therapy: A retrospective cohort study
62. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism
63. Cancer risk after iodine-131 therapy for hyperthyroidism
64. Cancer mortality following treatment for adult hyperthyroidism
65. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study
66. Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout
67. 131I or surgical treatment for toxic thyroid adenoma
68. Incidence, prevalence and characteristics of radiation-induced thyroid tumors
69. 131Iodine: Medical use. Carcinogenic and genetic effects
70. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring
71. Agranulocytosis and antithyroid drugs
72. Morbidity, mortality, and quality of life for patients treated with levothyroxine
73. Levothyroxine therapy in patients with thyroid disease
74. Foundations of cost-effectiveness analysis for health and medical practices
75. Recommendations of the Panel on Cost-effectiveness in Health and Medicine
76. The dilemma of the solitary thyroid nodule: Resolution through decision analysis
77. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma
78. Surgical therapy of toxic thyroid adenoma. Study of 630 cases
79. Optimized dose planning of radioiodine therapy of benign thyroidal diseases
80. The Markov process in medical prognosis